Trial intelligence / Profile preview

Open self-controlled phase IV study of Nicoflex ointment in knee osteoarthritis

2009-012433-30Phase 4Completed

Sponsor
Reanal
Start
Aug 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of Nicoflex in knee osteoarthritis (OA), sponsored by Reanal. Primary endpoints: Change in WOMAC index and Change in numeric rating scale for pain. Started Aug 2009; status: completed.

02

Drugs

Nicoflex
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on 2009-012433-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-012433-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call